Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma A system
收藏数据链接：
官方服务：
资源简介：
This is an original data from a systematic review and meta-analysis on the efficacy and safety of lenvatinib combined with transarterial chemoembolization (regardless of whether it is combined with programmed death-1 inhibitors) in the treatment of advanced hepatocellular carcinoma.
创建时间：
2025-06-05
